Laporte Jérôme, Savin Cyril, Lamourette Patricia, Devilliers Karine, Volland Hervé, Carniel Elisabeth, Créminon Christophe, Simon Stéphanie
CEA Saclay, iBiTec-S, Service de Pharmacologie et d'Immunoanalyse, Laboratoire d'Etudes et de Recherches en Immunoanalyse, Gif sur Yvette, France.
Institut Pasteur, Yersinia Research Unit, National Reference Laboratory and WHO Collaborating Center, Paris, France.
J Clin Microbiol. 2015 Jan;53(1):146-59. doi: 10.1128/JCM.02137-14. Epub 2014 Oct 29.
Yersinia enterocolitica and Yersinia pseudotuberculosis, the two Yersinia species that are enteropathogenic for humans, are distributed worldwide and frequently cause diarrhea in inhabitants of temperate and cold countries. Y. enterocolitica is a major cause of foodborne disease resulting from consumption of contaminated pork meat and is further associated with substantial economic cost. However, investigation of enteropathogenic Yersinia species is infrequently performed routinely in clinical laboratories because of their specific growth characteristics, which make difficult their isolation from stool samples. Moreover, current isolation procedures are time-consuming and expensive, thus leading to underestimates of the incidence of enteric yersiniosis, inappropriate prescriptions of antibiotic treatments, and unnecessary appendectomies. The main objective of the study was to develop fast, sensitive, specific, and easy-to-use immunoassays, useful for both human and veterinary diagnosis. Monoclonal antibodies (MAbs) directed against Y. enterocolitica bioserotypes 2/O:9 and 4/O:3 and Y. pseudotuberculosis serotypes I and III were produced. Pairs of MAbs were selected by testing their specificity and affinity for enteropathogenic Yersinia and other commonly found enterobacteria. Pairs of MAbs were selected to develop highly sensitive enzyme immunoassays (EIAs) and lateral flow immunoassays (LFIs or dipsticks) convenient for the purpose of rapid diagnosis. The limit of detection of the EIAs ranged from 3.2 × 10(3) CFU/ml to 8.8 × 10(4) CFU/ml for pathogenic serotypes I and III of Y. pseudotuberculosis and pathogenic bioserotypes 2/O:9 and 4/O:3 of Y. enterocolitica and for the LFIs ranged from 10(5) CFU/ml to 10(6) CFU/ml. A similar limit of detection was observed for artificially contaminated human feces.
小肠结肠炎耶尔森菌和假结核耶尔森菌这两种对人类具有肠道致病性的耶尔森菌属细菌分布于全球,在温带和寒冷国家的居民中常引发腹泻。小肠结肠炎耶尔森菌是食用受污染猪肉导致食源性疾病的主要病因,还会造成巨大的经济损失。然而,由于其特殊的生长特性,临床实验室很少常规检测肠道致病性耶尔森菌,这使得从粪便样本中分离它们变得困难。此外,目前的分离程序既耗时又昂贵,从而导致肠道耶尔森菌病发病率被低估、抗生素治疗处方不当以及不必要的阑尾切除术。该研究的主要目标是开发快速、灵敏、特异且易于使用的免疫测定方法,用于人类和兽医诊断。制备了针对小肠结肠炎耶尔森菌生物血清型2/O:9和4/O:3以及假结核耶尔森菌血清型I和III的单克隆抗体(MAbs)。通过测试它们对肠道致病性耶尔森菌和其他常见肠道细菌的特异性和亲和力来选择单克隆抗体对。选择单克隆抗体对来开发高度灵敏的酶免疫测定法(EIAs)和侧向流动免疫测定法(LFIs或试纸条),以便于快速诊断。EIAs对假结核耶尔森菌致病性血清型I和III以及小肠结肠炎耶尔森菌致病性生物血清型2/O:9和4/O:3的检测限范围为3.2×10³CFU/ml至8.8×10⁴CFU/ml,而LFIs的检测限范围为10⁵CFU/ml至10⁶CFU/ml。在人工污染的人类粪便中也观察到了类似的检测限。